Cranbrook Wealth Management’s Ionis Pharmaceuticals IONS Stock Holding History

Cranbrook Wealth Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25	Closed	-$1K	–	299
2022 Q3	$1K	Hold	25	–	–	﹤0.01%	297
2022 Q2	$1K	Hold	25	–	–	﹤0.01%	294
2022 Q1	$1K	Hold	25	–	–	﹤0.01%	335
2021 Q4	$1K	Hold	25	–	–	﹤0.01%	347
2021 Q3	$1K	Hold	25	–	–	﹤0.01%	416
2021 Q2	$1K	Hold	25	–	–	﹤0.01%	337
2021 Q1	$1K	Hold	25	–	–	﹤0.01%	375
2020 Q4	$1K	Hold	25	–	–	﹤0.01%	307
2020 Q3	$1K	Hold	25	–	–	﹤0.01%	257
2020 Q2	$1K	Hold	25	–	–	﹤0.01%	254
2020 Q1	$1K	Hold	25	–	–	﹤0.01%	247
2019 Q4	$2K	Hold	25	–	–	﹤0.01%	241
2019 Q3	$1K	Hold	25	–	–	﹤0.01%	258
2019 Q2	$2K	Hold	25	–	–	﹤0.01%	223
2019 Q1	$2K	Hold	25	–	–	﹤0.01%	222
2018 Q4	$1K	Hold	25	–	–	﹤0.01%	227
2018 Q3	$1K	Hold	25	–	–	﹤0.01%	222
2018 Q2	$1K	Hold	25	–	–	﹤0.01%	212
2018 Q1	$1K	Hold	25	–	–	﹤0.01%	213
2017 Q4	$1K	Hold	25	–	–	﹤0.01%	210
2017 Q3	$1K	Hold	25	–	–	﹤0.01%	211
2017 Q2	$1K	Hold	25	–	–	﹤0.01%	217
2017 Q1	$1K	Hold	25	–	–	﹤0.01%	201
2016 Q4	$1K	Hold	25	–	–	﹤0.01%	206
2016 Q3	$1K	Hold	25	–	–	﹤0.01%	198
2016 Q2	$1K	Hold	25	–	–	﹤0.01%	182
2016 Q1	$1K	Hold	25	–	–	﹤0.01%	194
2015 Q4	$2K	Hold	25	–	–	﹤0.01%	185
2015 Q3	$1K	Hold	25	–	–	﹤0.01%	201
2015 Q2	$1K	Hold	25	–	–	﹤0.01%	204
2015 Q1	$2K	Hold	25	–	–	﹤0.01%	199
2014 Q4	$2K	Hold	25	–	–	﹤0.01%	200
2014 Q3	$1K	Hold	25	–	–	﹤0.01%	150
2014 Q2	$1K	Hold	25	–	–	﹤0.01%	148
2014 Q1	$1K	Hold	25	–	–	﹤0.01%	147
2013 Q4	$1K	Buy	+25	New	+$891	﹤0.01%	211

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Cranbrook Wealth Management's IONS Position: Q4 2022 in Review

Cranbrook Wealth Management sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 25 shares — an estimated $1K sold.

Cranbrook Wealth Management first reported a position in IONS in Q4 2013 and held it in 36 quarters. The position peaked at $2K in Q4 2019. 338 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

Cranbrook Wealth Management reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Cranbrook Wealth Management sold 25 Ionis Pharmaceuticals shares in Q4 2022, an estimated $1K.
Cranbrook Wealth Management first reported a position in Ionis Pharmaceuticals in Q4 2013 and held it in 36 quarters.
Cranbrook Wealth Management's Ionis Pharmaceuticals position peaked at $2K in Q4 2019.
338 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on Cranbrook Wealth Management's 13F filing for Q4 2022, filed 9 Feb 2023.